Abstract
Species of Aspergillus are ubiquitous saprobes in nature, but some have been implicated in a wide spectrum of human diseases ranging from asthma in atopic individuals to invasive systemic aspergillosis in immunocompromised patients (Kurup and Apter 1998). Various species have frequently been isolated from freshly dug fields, compost piles, potting soil, mulches, sewage facilities, and bird excreta (Kramer et al. 1989; Kurup and Kumar 1991; Fink and Kurup 1997; Kurup and Banerjee 1997; Summerbell 1998). Although the genus Aspergillus contains over 130 species, only a few have been shown to be associated with human diseases (Summerbell 1998). Among them, Aspergillus fumigatus (Fig. 12.1A) is the most common fungus associated with various types of diseases in humans. A. fumigatus grows at temperatures ranging from 15–53 °C. The conidia of A. fumigatus are produced in specialized stalks and range from 1–3 mm in diameter (Fig. 12.1B).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arruda LL, Platts-Mills TAE, Fox JW, Chapman MD (1990) Aspergillus fumigatus allergen 1, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins. J Exp Med 172:1529–1532
Banerjee B, Kurup VP (1998) Molecular biology of Aspergillus allergens. In: Kurup VP, Apter AJ (eds) Immunology and allergy clinics of North America, vol 18. Saunders, Philadelphia, pp 601–618
Banerjee B, Kurup VP, Phadnis S, Greenberger PA, Fink JN (1996) Molecular cloning and expression of a recombinant Aspergillus fumigatus protein Aspf II with significant IgE reactivity in allergic bronchopulmonary aspergillosis. J Lab Clin Med 127:253–262
Banerjee B, Kurup VP, Greenberger PA, Hoffman DR, Nair DS, Fink JN (1997) Purification of a major allergen, Asp f 2 binding to IgE in allergic bronchopulmonary aspergillosis, from culture filtrate of Aspergillus fumigatus. J Allergy Clin Immunol 99:821–827
Banerjee B, Greenberger PA, Fink JN, Kurup VP (1999) Conformational and linear B-cell epitopes of Asp f 2, a major allergen of Aspergillus fumigatus, bind differently to immunoglobulin E antibody in the sera of allergic bronchopulmonary aspergillosis patients. Infect Immun 67:2284–2291
Banerjee B, Greenberger PA, Fink JN, Kurup VP (2000) Molecular characterization of Aspergillus fumigatus allergens. Indian J Chest Dis Allied Sci 42:239–248
Banerjee B, Xia J-Q, Rickaby DA, Henderson JD, Kelly KJ, Fink JN, Kurup VP (2001) Modulation of airway inflammatory CpG oligodeoxynucleotide in a murine model of aspergillosis (abstract). J Allergy Clin Immunol 107:S216
Bhargava V, Tomashefski J, Stern R, Abramowsky C (1989) The pathology of fungal infection and colonization in patients with cystic fibrosis. Hum Pathol 20:977–986
Blau H, Riklis S, Van Iwaarden JF, McCormack FX, Kalina M (1997) Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein. Am J Physiol 272:1198–1204
Blease K, Mehrad B, Standiford TJ, Lukacs NW, Gosling J, Boring L, Charo IF, Kunkel SL, Hogaboam CM (2000a) Enhanced pulmonary allergic responses to Aspergillus in CCR2 -/- mice. J Immunol 165: 2603–2611
Blease K, Mehrad B, Standiford TJ, Lukacs NW, Kunkel SL, Chensue SW, Lu B, Gerard CJ, Hogaboam CM (2000b) Airway remodeling is absent in CCR1-/- mice during chronic fungal allergic airway disease. J Immunol 165: 1564–1572
Blease K, Jakubzick C, Westwick J, Lukacs N, Kunkel SL, Hogaboam CM (2001) Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol 166:5219–5224
Brinker KG, Martin E, Borron P, Mostaghel E, Doyle C, Harding CV, Wright JR(2001) Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol 28:1453–1463
Brummund W, Resnick A, Fink JN, Kurup VP (1987) Aspergillus fumigatus-specific antibodies in allergic bronchopulmonary aspergillosis and aspergilloma: evidence for a polyclonal antibody response. J Clin Microbiol 25:5–9
Cenci E, Perito S, Enssle KH, Mosci P, Latgé JP, Romani L, Bistoni F (1997) Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 65:564–570
Cenci E, Mencacci A, Bacci A, Bistoni F, Kurup VP, Romani L (2000) T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 165:381–388
Chauhan B, Knutsen AP, Hutcheson PS, Slavin RG, Bellone CJ (1996) T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 97:2324–2331
Chauhan B, Santiago L, Kirschmann DA, Hauptfeld V, Knutsen AP, Hutcheson PS, Woulfe SL, Slavin RG, Schwartz HJ, Bellone CJ (1997) The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 159: 4072–4076
Chen HH (1998) Radiologic aspects of allergic bronchopulmonary aspergillosis. In: Kurup VP, Apter AJ (eds) Immunology and allergy clinics of North America, vol 18. Saunders, Philadelphia, pp 509–524
Chu HW, Wang JM, Boutet M, Laviolette M (1995) Increased expression of intracellular adhesion molecule-1 (ICAM-1) in a murine model of pulmonary eosinophilia and high IgE level. Clin Exp Immunol 100:319–324
Chu HW, Wang JM, Boutet M, Boulet LP, Laviolette M (1996) Immunohistochemical detection of GM-CSF, IL-4 and IL-5 in a murine model of allergic bronchopulmonary aspergillosis. Clin Exp Allergy 26: 461–468
Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, Rennick DM, Lockesley RM (1998) Requirements for allergen-induced airway hyperreactivity in T- and B-cell-deficient mice. Mol Med 4:344–355
Crameri R (1997) pJuFo: a phage surface display system for cloning genes based on protein-ligand interaction. In: Schaefer BC (ed) Gene cloning and analysis. Current innovations. Horizon Scientific Press, Whymondham, pp 29–42
Crameri R (1998) Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int Arch Allergy Immunol 115:99–114
Crameri R, Walter G (1999) Selective enrichment and highthroughput screening of phage surface displayed cDNA libraries from complex allergenic systems. Comb Chem High Throughput Screen 2:63–72
Crameri R, Jaussi R, Menz G, Blaser K (1994) Display of expression products of cDNA libraries on phage surfaces: a versatile screening system for selective isolation of genes by specific gene product/ligand interaction. Eur J Biochem 226:53–58
Crameri R, Faith A, Hemmann S (1996a) Humoral and cellmediated autoimmunity in allergy to Aspergillus fumigatus. J Exp Med 184:265–270
Crameri R, Hemmann S, Blaser K (1996b) pJuFo: a phagemid for display of cDNA libraries on phage surface suitable for selective isolation of clones expressing allergens. Adv Med Exp Biol 409:103–110
Crameri R, Lidholm J, Menz G, Gronlung H, Blaser K (1996c) Automated serology with recombinant allergens. Adv Med Exp Biol 409:111–116
Crameri R, Hemmann S, Ismail C, Menz G, Blaser K (1998) Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int Immunol 10:1211–1216
Day JH (1996) Allergic respiratory responses to fungi. In: Howard DH, Miller JD (eds) The Mycota, vol VI. Springer, Berlin Heidelberg New York, pp 173–192.
Denning DW (1998) Invasive aspergillosis. Clin Infect Dis 26:781–803
Fink JN, Kurup VP (1997) Allergic bronchopulmonary aspergillosis. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ (eds) Asthma, vol 2. Lippincott-Raven, Philadelphia, pp 2077–2087
Ford JG, Rennick D, Donaldson DD, Venkayya R, McArthur C, Hansell E, Kurup VP, Warnock M, Grunig G (2001) IL-13 and IFN-y interactions in lung inflammation. J Immunol 167:1769–1777
Greenberger PA (1988a) Allergic bronchopulmonary aspergillosis. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW (eds) Allergy principle and practice. Mosby, St Louis, pp 1219–1236
Greenberger PA (1988b) Allergic bronchopulmonary aspergillosis and fungoses. Clin Chest Med 9:599–608
Grünig G, Corry DB, Leach MW, Seymour BWP, Kurup VP, Rennick DM (1997) Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 185:1089–1099
Grünig G, Corry DB, Coffman RL, Rennick DM, Kurup VP (1998) Animal models of allergic bronchopulmonary aspergillosis. In: Kurup VP, Apter AJ (eds) Immunology and allergy clinics of North America, vol 18. Saunders, Philadelphia, pp 661–679
Hearn VM, Proctor AG, MacKenzie DWR (1980) The preparation and partial characterization of antigenic fractions obtained from the mycelial walls of several Aspergillus species. J Gen Microbiol 119:41–49
Hogaboam CM, Gallinat CS, Taub DD, Striter RM, Kunkel SL, Lukacs NW (1999) Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis. J Immunol 162: 6071–6079
Hogaboam CM, Blease K, Mehrad B, Steinhauer ML, Standiford TJ, Kunkel SL, Lukacs NW (2000) Chronic airway hyperreactivity goblet cell hyperplasma and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Path 156:723–732
Hoyne CF, Callow MG, Kuo MC, Thomas WR (1994) Inhibition of T-cell responses by feeding peptides containing major and cryptic epitopes: studies with Der p 1 allergen. Immunology 83:190–195
Katzenstein A-L, Liebow A, Friedman P (1975) Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. Am Rev Respir Dis 111:497–537
Katzenstein A-L, Sale S, Greenberger P (1983) Pathologic findings in allergic Aspergillus sinusitis. A newly recognized form of sinusitis. Am J Surg Pathol 7:439–443
Kauffman HF, Tomee JFC (1998) Inflammatory cells and airway defense against Aspergillus fumigatus. In: Kurup VP, Apter AJ (eds) Immunology and allergy clinics of North America, vol 18. Saunders, Philadelphia, pp 619–640
Kauffman HF, Tomee JFC, van de Riet MA, Timmerman AJB, Borger P (2000) Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 105:1185–1193
Knutsen AP, Mueller KR, Hutcheson PS, Slavin GR (1990) T- and B-cell dysregulation in cystic fibrosis patients with allergic bronchopulmonary aspergillosis. Clin Immunol Immunopathol 55:129–138
Knutsen AP, Muell KR, Levine AD, Chauhan B, Hutcheson PS, Slavin RG (1994) Asp f 1 CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 94:215–221
Knutsen AP, Chauhan B, Slavin RG (1998) Cell-mediated immunity in allergic bronchopulmonary aspergillosis. In: Kurup VP, Apter AJ (eds) Immunology and allergy clinics of North America, vol 18. Saunders, Philadelphia, pp 575–599
Kramer MN, Kurup VP, Fink JN (1989) Allergic bronchopulmonary aspergillosis from a contaminated dump site. Am Rev Respir Dis 140:1086–1088
Kumar A, Kurup VP, Greenberger PA, Fink JN (1993) Production and characterization of a monoclonal antibody to a major concanavalin A-nonbinding antigen of Aspergillus fumigatus. J Lab Clin Med 121:431–436
Kurup VP (2000) Immunology of allergic bronchopulmonary aspergillosis. Indian J Chest Dis Allied Sci 42:225–237
Kurup VP, Apter AJ (ed) (1998) Immunology and allergy clinics of North America 18. Saunders, Philadelphia
Kurup VP, Banerjee B (1997) Allergic aspergillosis: antigens and immunodiagnosis. Adv Med Mycol 2:133–154
Kurup VP, Banerjee B (2000) Fungal allergens and peptide epitopes. Peptides 21:589–599
Kurup VP, Crameri R (2000) Aspergillus allergens. http://www.aspergillus.man.ac.uk/secure/article/kurup/index.html
Kurup VP, Kumar A (1991) Immunodiagnosis of aspergillosis. Clin Microbiol Rev 4:439–456
Kurup VP, Fink JN, Scribner GH, Falk MJ (1978) Antigenic variability of Aspergillus fumigatus strains. Microbios 19:191–204
Kurup VP, Nair MPN, Schwartz SA, Fink JN (1985) Serum antibodies and their role in antibody-dependent cellmediated cytotoxicity in aspergillosis. Immunolbiol 169:362–371
Kurup VP, Resnick A, Kalbfleish J, Fink JN (1990) Antibody isotype responses in Aspergillus-induced diseases. J Lab Clin Med 115:298–303
Kurup VP, Mauze S, Choi HY, Seymour BWP, Coffman RL (1992) A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J Immunol 148:3783–3788
Kurup VP, Seymour BWP, Choi H, Coffman RL (1994) Particulate Aspergillus fumigatus antigens elicit a Th2 response in BALB/c mice. J Allergy Clin Immunol 93:1013–1020
Kurup VP, Hari V, Guo J, Murali PS, Resnick A, Krishnan M, Fink JN (1996) Aspergillus fumigatus peptides differentially express Th 1 and Th2 cytokines. Peptides 17: 183–190
Kurup VP, Guo J, Murali PS, Choi H, Fink JN (1997a) Immunopathological responses to Aspergillus antigen in interleukin-4 knockout mice. J Lab Clin Med 130: 567–575
Kurup VP, Murali PS, Guo J, Choi H, Banerjee B, Fink JN, Coffman RL (1997b) Anti-IL-4 and IL-5 antibodies downregulate IgE and eosinophilia in mice exposed to Aspergillus antigens. Allergy 52:1215–1221
Kurup VP, Banerjee B, Murali PS, Greenberger PA, Krishnan M, Hari V, Fink JN (1998) Immunodominant peptide epitopes of allergen, Asp f 1 from the fungus Aspergillus fumigatus. Peptides 19:1469–1477
Kurup VP, Choi HY, Murali PS, Xia J-Q, Coffman, Fink JN (1999) Immune responses to Aspergillus antigen in IL4 -/- mice and the effect of eosinophil ablation. Allergy 54:420–427
Kurup VP, Banerjee B, Hemmann S, Greenberger PA, Blaser K, Crameri R (2000) Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 30:988–993
Lin W-L, Chou H, Tam MF, Huang M-H, Han S-H, Shen HD (2000) Production and characterization of monoclonal antibodies to serine proteinase allergens in Penicillium and Aspergillus species. Clin Exp Allergy 30:1653–1662
Longbottom JL (1986) Antigens and allergens of Aspergillus fumigatus, II: their further identification and partial characterization of a major allergen (Ag3). J Allergy Clin Immunol 78:18–24
Lukacs NW, Strieter RM, Warmington K, Lincoln P, Chensue SW, Kunkel SL (1997) Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 158: 4398–4404
Madan T, Banerjee B, Bhatnagar PK, Shah A, Sarma PU (1997a) Identification of 45 Kda antigen in immune complexes of patients of allergic bronchopulmonary aspergillosis. Mol Cell Biochem 166:111–116
Madan T, Eggleton P, Kishore U, Strong P, Aggrawal SS, Sarma PU, Reid KB (1997b) Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 65:3171–3179
Madan T, Kishore U, Shah A, Eggleton P, Strong P, Wang JY, Aggrawal SS, Sarma PU, Reid KB (1997c) Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin Exp Immunol 110:241–249
Madan T, Kishore U, Singh M, Strong P, Clark H, Hussain EM, Reid KBM, Sarma PU (2001a) Lung surfactant protein a (sp-a) and d (sp-d) suppress eosinophilia and specific IgE antibodies in a murine model of fungal hypersensitivity. J Clin Invest 107:467–475
Madan T, Kishore U, Singh M, Strong P, Hussain EM, Reid KBM, Sarma PU (2001b) Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect Immun 69:2728–2731
Mehlhop PD, van de Rijn M, Goldberg AB, Brewer JP, Kurup VP, Martin TR, Oettgen HC (1997) Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA 94:1344–1349
Mochizuki M, Bartels J, Mallet AI, Christophers E, Schroder J-M (1998) IL-4 induces eotaxin: A possible mechanism of selective recruitment in helminth infection and atopy. J Immunol 160:60–68
Moser M, Crameri R, Brust E, Suter M, Menz G (1994) Diagnostic value of recombinant Aspergillus fumigatus allergen I/a for skin testing and serology. J Allergy Clin Immunol 93:1–11
Murali PS, Dai G, Kumar A, Fink JN, Kurup VP (1992a) Aspergillus antigen-induced eosinophil differentiation in a murine model. Infect Immun 60:1952–1956
Murali PS, Kurup VP, Greenberger PA, Fink JN (1992b) Concanavalin A-nonbinding Aspergillus fumigatus antigen: a major immunogen in allergic bronchopulmonary aspergillosis. J Lab Clin Med 119:377–384
Murali PS, Pathial K, Saff RH, Splaingard ML, Atluru D, Kurup VP, Fink JN (1994) Immune responses to Aspergillus fumigatus and Pseudomonas aeruginosa antigens in cystic fibrosis and allergic bronchopulmonary aspergillosis. Chest 106:513–519
Murali PS, Greenberger PA, Kurup VP (1998a) Cytokines in allergic bronchopulmonary aspergillosis. In: Kurup VP, Apter AJ (eds) Immunology and allergy clinics of North America, vol 18. Saunders, Philadelphia, pp 681–694
Murali PS, Kurup VP, Bansal NK Fink JN, Greenberger PA (1998b) IgE down regulation and cytokine induction by Aspergillus antigens in human allergic bronchopulmonary aspergillosis. J Lab Clin Med 131: 228–235
Myers JL (1995) Pathology of allergic bronchopulmonary aspergillosis. In: Patterson R, Greenberger PA, Roberts ML (eds) Allergic bronchopulmonary aspergillosis. Ocean Side Publications, Providence, pp 39–46
Nagai H, Guo J, Choi H, Kurup V (1995) Interferon-y and tumor necrosis factor-a protect mice from invasive aspergillosis. J Infect Dis 172:1554–1560
Nigam S, Sarma PVGK, Ghosh PC, Sarma PU (2001) Characterization of Aspergillus fumigatus protein disulfide isomerase family gene. Gene 281:143–150
(in press) Patterson R, Rosenberg M, Roberts M (1977) Evidence that Aspergillus fumigatus growing in the airway of man can be a potent stimulus of specific and nonspecific IgE formation. Am J Med 63:257–262
Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M (1986) Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch Intern Med 146:916–918
Pearson AM (1996) Scavenger receptors in innate immunity. Curr Opion Immunol 8:20–28
Riley RT, Norred WP (1996) Mechanisms of mycotoxicity. In: Howard DH, Miller JD (eds) The Mycota, vol VI Springer, Berlin Heidelberg New York, pp 193–212
Rhodes JC, Amlung TW, Miller MS (1990) Isolation and characterization of an elastinolytic protease from Aspergillus flavus. Infect Immun 58:2529–2534
Rosenberg M, Mintzer R, Aaronson DW, Patterson R (1977a) Allergic bronchopulmonary aspergillosis in three patients with normal chest X-ray films. Chest 72:597–600
Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE (1977b) Clinical and immunological criteria for the diagnosis of ABPA. Ann Intern Med 86:405–414
Rosenberg AH, Lade BN, Chui D, Lin SW, Dunn JJ, Studier FW (1987) Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene 56:125–135
Sarma PU, Banerjee B, Bir N, Kurup VP (1998) Immunodiagnosis of allergic bronchopulmonary aspergillosis. In: Kurup VP, Apter AJ (eds) Immunology and allergy clinics of North America, vol 18. Saunders, Philadelphia, pp 525–547
Sarma PVGK, Purkayastha S, Madan T, Sarma PU (1999) Expression of an epitopic region of Asp f 1, an allergen/antigen/cytotoxin of Aspergillus fumigatus. Immunol Lett 170:151–155
Studier FW, Rosenberg AH, Dunn JJ (1990) Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185:60–89
Summerbell RC (1998) Taxonomy and ecology of Aspergillus species associated with colonizing infections of the respiratory tract. In: Kurup VP, Apter AJ (eds) Immunology and allergy clinics of North America, vol 18. Saunders, Philadelphia, pp 549–573
Svirshchevskaya E, Frolova E, Alekseeva L, Kotzareva O, Kurup VP (2000) Intravenous injection of major and cryptic peptide epitopes of ribotoxin, Asp f1 inhibits T cell response induced by crude Aspergillus fumigatus antigens in mice. Peptides 21:1–8
Svirshchevskaya EV, Alekessva LG, Andronova TM, Kurup VP (2001) Do T helpers 1 and 2 recognize different class II MHC molecules? Humoral and cellular immune responses to soluble allergen from Aspergillus fumigatus Asp f 2. Clin Immunol 100: 349–354
Tang B, Banerjee B, Greenberger PA, Fink JN, Kelly KJ, Kurup VP (2000) Antibody binding of deletion mutants of Asp f 2, the major Aspergillus fumigatus allergen. Biochem Biophy Res Com 270:1128–1135
Tomee JFC, Hiemstra PS, Heinsel-Weiland R, Kauffman HF (1997) Anti-leukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis 176:740–747
Tomee JFC, Koeter GH, Kauffman HF (1998) Secretory leukoprotease inhibitor: a native anti-microbial protein presenting new therapeutic options? Thorax 53: 114–116
Varkey B (1998) Allergic bronchopulmonary aspergillosis (clinical perspective). In: Kurup VP, Apter AJ (eds) Immunology and allergy clinics of North America, vol 18. Saunders, Philadelphia, pp 549–573
Wang JM, Denis M, Fournier M, Laviolette M (1994) Experimental allergic bronchopulmonary aspergillosis in the mouse: immunological and histological features. Scand J Immunol 39:19–26
Wanner A, Salathe M, O’Riordan TG (1996) Mucociliary clearance in the airways. Am J Resp Crit Care Med 154:1868–1902
Zacharisen MC, Kadambi AR, Schlueter DP, Kurup VP, Shack JB, Fox JL, Anderson HA, Fink JN (1998) The spectrum of respiratory disease associated with exposure to metal working fluids. JOEM 40:640–647
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kurup, V.P., Madan, T., Sarma, U.P. (2004). Allergic Bronchopulmonary Aspergillosis: Recent Concepts and Considerations. In: Domer, J.E., Kobayashi, G.S. (eds) Human Fungal Pathogens. The Mycota, vol 12. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10380-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-10380-7_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-07651-0
Online ISBN: 978-3-662-10380-7
eBook Packages: Springer Book Archive